Categories
Investment

OpenFin secures $35 mn in Series D investment

OpenFin, the operating system (OS) of enterprise productivity, announced that it has secured $35 million in Series D investment. The latest funding round was led by Bank of America with significant participation from Pivot Investment Partners and ING Ventures. Additional investors in the round include CME Ventures, CTC Venture Capital, SC Ventures and Tribeca Early Stage Partners. […]

Categories
Executive Movements

Bank of America names José E. Almeida to its Board

The Bank of America Corporation Board of Directors appointed José (Joe) E. Almeida as a director, effective immediately. Almeida, 59, serves as chairman, president and chief executive officer of Baxter International Inc., a position he has held since 2016. Before joining Baxter, Almeida served as chairman, president and chief executive officer of Covidien plc from 2012 […]

Categories
Global Investment

AlphaSense Raises $180 Million Series C Led by Viking Global and Goldman Sachs

New York-based AlphaSense, the market intelligence and search platform, has announced its $180 million Series C financing round led by Viking Global Investors and the Growth Equity business within Goldman Sachs Asset Management (Goldman Sachs), joined by Morgan Stanley, Citi, Bank of America, Barclays, Wells Fargo Strategic Capital, Cowen Inc., and AllianceBernstein, as well as […]

Categories
Executive Movements

Bank of America makes leadership changes; names Aditya Bhasin as Chief Technology & Information Officer

Bank of America announced senior leadership changes to its management team. The company announced adding of five new members, including three women, to the senior management team. When all of the changes are complete, Bank of America’s senior management team will include individuals with an average of 21 years of service in the company and […]

Categories
Corporate

CureVac aims to raise up to $245 mn in US IPO

CureVac, a leading clinical stage biotechnology company in the field of messenger RNA and one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial public offering (IPO) on the US Nasdaq, according to Reuters. The biotech firm said it plans to offer a […]